“Show me the money.”
The classic line from the film “Jerry Maguire” reverberates through many of the pitches entrepreneurs make to investors for funding.
In one sense, of course, the line – and the approach – is perfectly appropriate.
Kevin Huhn
Kevin Huhn's Latest Posts
Disagreements among lawmakers stall delta-8 THC ban in Washington state
Last-minute disagreements about the rise of hemp-derived THC products in Washington state derailed legislative proposals to ban the sale of delta-8 THC derived from hemp extracts.
Cash-flow pain for your cannabis business? Try receivables factoring
If your cannabis business lacks financial flexibility, you might consider a special type of financing called “receivables factoring.”
A factor can help speed things along and get you the cash you need to take care of business.
THC warning, raids prompt hemp lawsuit in Georgia
A Georgia county near Atlanta is wrongly seizing hemp-derived THC products and scaring businesses away from legal products, according to a lawsuit seeking to stop the practice.
Can potential growth aid this cannabis stock? + strategic planning alternative
The Kanabo Group is banking on potential growth to correct its stock trend, and how to best use scenario planning in lieu of strategic planning.
A case against issuing warrants + exploiting marijuana rule changes
Examining Enveric Biosciences’ recent issuance of warrants, and the importance of marijuana businesses exploiting changes in their markets.
Specifications that rely solely on limits of detection ultimately fail cannabis consumers
Cannabis testing and label failures are huge challenges for the industry, as attorney Ian A. Stewart pointed out in his recent analysis of the “perverse incentives” that marijuana regulations facilitate when products are tested and allowed to pass specifications based on limit of detection (LOD).
Cannabis company Hexo experiences pitfall of listing on public exchange
One of the big attractions of listing on a public exchange is increased access to capital.
One of the drawbacks, however, is mandatory compliance with additional securities requirements.
Why IIP canceled a cannabis notes issue + NY adult-use permits in jeopardy
Innovative Industrial Properties (NYSE: IIPR), the largest REIT focused on the cannabis industry, on Feb. 1 announced a $300 million, six-year senior unsecured note offering at its IIP Operating Partnership level.
Australian cannabis company to enter US through $21 million CBD acquisition
Creso Pharma said it is buying Colorado-based CBD maker Sierra Sage Herbs in an all-stock deal worth $21 million, positioning the Australian cannabis producer to enter the U.S. market.
Winter Olympics feature Canadian hemp fibers in luge, bobsled tracks
Canadian Greenfield Technologies, an engineering and manufacturing company specializing in hemp products, sent more than 60,000 pounds of its NForce-Fiber for use in the luge and bobsled tracks at the 2022 Winter Olympics that opened Friday in Beijing.
US House passes measure that includes cannabis banking
The U.S. House of Representatives passed an American competitiveness bill Friday that includes legislation that would enable banks to serve cannabis businesses without fear of reprisal, but it’s unclear whether the measure will pass the full Congress.
